qazcovid-in
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Sep 19, 2020 (NCT04530357)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04930003 | Phase 1/Phase 2 (Phase 2) | Jun 15, 2021 | Research Institute for Biological Safety Problems |
| NCT04691908 | Phase 3 | Dec 25, 2020 | City polyclinic No. 4 of the UZO of Almaty, Clinic of the International Institute of Postgraduate Education, Government of Kazakhstan, Research Institute for Biological Safety Problems |
| NCT04530357 | Phase 1/Phase 2 (Phase 2) | Sep 19, 2020 | Government of Kazakhstan, Research Institute for Biological Safety Problems |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Research Institute for Biological Safety Problems | Academic/Hospital | 3 | 3 | 2 | 2020 |
| Government of Kazakhstan | Government | 2 | 0 | 2 | 2020 |
| City polyclinic No. 4 of the UZO of Almaty | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Clinic of the International Institute of Postgraduate Education | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1